Robotic-assisted gastrectomy for gastric cancer: single Western center results

Updates Surg. 2021 Jun;73(3):865-872. doi: 10.1007/s13304-020-00896-2. Epub 2020 Oct 14.

Abstract

A robotic approach to abdominal surgery procedures may improve postoperative outcomes compared to either open or laparoscopic approaches. The role of robotics for gastric surgery, however, is still being evaluated. A retrospective review of the prospectively maintained database for robotic gastric surgery at University of Siena between 2011 and 2020 was conducted. Data regarding surgical procedures, early postoperative outcomes, and long-term follow-up were analyzed. 38 patients underwent robotic partial or total gastrectomy. Conversion to open occurred in two patients (5.2%) due to locally advanced disease as well as difficult identification of primary lesion. Postoperative morbidity was 13.1% while no postoperative mortality was registered. The mean length of operation was 358.6 (220-650) minutes and the mean number of retrieved lymph nodes was 35.8 (range: 5-73). The median OS of all population was 70.9 months. The median 5-year OS for the patients with positive nodes was worse than that of patients without metastatic lymph nodes [51.4 months (95% CI 35.5-67.4) vs. 79.5 months (95% CI 67.1-91.8); p = 0.079]. The interesting results including postoperative morbidity as well as mortality rate, the surgical outcomes, and the 5-year OS, were to be acceptable considering the data recorded by previous studies on robotic gastrectomy. This study demonstrated that robotic gastrectomy is feasible and can be safely performed. However, further follow-up and randomized clinical trials are required to confirm the role of a robotic approach in gastric cancer surgery.

Keywords: D2 lymphadenectomy; Gastric cancer; Robotic gastrectomy; Survival.

MeSH terms

  • Gastrectomy
  • Humans
  • Laparoscopy*
  • Lymph Node Excision
  • Retrospective Studies
  • Robotic Surgical Procedures*
  • Stomach Neoplasms* / surgery
  • Treatment Outcome